Context Therapeutics Inc (CNTX)

Oct 14, 2025

Does Context Therapeutics Inc. stock trade at a discount to peersWeekly Investment Report & AI Based Buy and Sell Signals - newser.com

Oct 14, 2025

Oct 14, 2025

Momentum divergence signals in Context Therapeutics Inc. chartGap Down & Stepwise Trade Signal Implementation - newser.com

Oct 14, 2025

Oct 14, 2025

Is Context Therapeutics Inc. stock positioned well for digital economyWeekly Market Outlook & Accurate Intraday Trade Tips - newser.com

Oct 14, 2025

Oct 14, 2025

Is Context Therapeutics Inc. stock in correction or buying zone2025 EndofYear Setup & Growth Focused Stock Reports - newser.com

Oct 14, 2025

Oct 13, 2025

How to use Fibonacci retracement on Context Therapeutics Inc.2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Can a trend reversal in Context Therapeutics Inc. lead to recoveryEarnings Recap Report & Fast Moving Stock Watchlists - newser.com

Oct 13, 2025

Oct 12, 2025

Context Therapeutics to Present New Data on Two Bispecific T Cell Engagers at SITC 2025 - MyChesCo

Oct 12, 2025

Oct 11, 2025

Context Therapeutics to Showcase CT-95 Data at AACR 2025 - MSN

Oct 11, 2025

Oct 11, 2025

What drives Context Therapeutics Inc stock priceCandlestick Trading Patterns & Unlock Patterns Humans Can’t See - earlytimes.in

Oct 11, 2025

Oct 10, 2025

Is Context Therapeutics Inc. stock ready for a breakoutNew Guidance & Low Risk Entry Point Tips - newser.com

Oct 10, 2025

Oct 10, 2025

Will Context Therapeutics Inc. continue its uptrendLayoff News & AI Based Buy and Sell Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Historical volatility pattern of Context Therapeutics Inc. visualizedQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com

Oct 10, 2025

Oct 10, 2025

Real time social sentiment graph for Context Therapeutics Inc.Portfolio Update Summary & Free Weekly Watchlist of Top Performers - newser.com

Oct 10, 2025

Oct 10, 2025

Live market analysis of Context Therapeutics Inc.July 2025 Market Mood & Stepwise Swing Trade Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Context Therapeutics Inc. stock momentum explained2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Context Therapeutics (NASDAQ:CNTX) - MarketBeat

Oct 09, 2025

Oct 09, 2025

How Context Therapeutics Inc. stock trades before earningsQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com

Oct 09, 2025

Oct 09, 2025

Is a relief rally coming for Context Therapeutics Inc. holdersIndex Update & AI Driven Stock Reports - newser.com

Oct 09, 2025

Oct 09, 2025

Is Context Therapeutics Inc. showing signs of accumulationEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com

Oct 09, 2025

Oct 08, 2025

Institutions profited after Context Therapeutics Inc.'s (NASDAQ:CNTX) market cap rose US$14m last week but private equity firms profited the most - Yahoo Finance

Oct 08, 2025

Oct 07, 2025

Context Therapeutics Inc. (NASDAQ:CNTX) Receives $5.20 Consensus PT from Analysts - Defense World

Oct 07, 2025

Oct 06, 2025

Context Therapeutics Grants Stock Options to New Hire - MSN

Oct 06, 2025

Oct 06, 2025

Will Context Therapeutics Inc. see short term momentumJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Announces Poster Presentations at the - GlobeNewswire

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Inc. to Present Trial Progress and Preclinical Data at SITC 2025 Annual Meeting - Quiver Quantitative

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of ... - Caledonian Record

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Stock Titan

Oct 06, 2025

Oct 06, 2025

Is it too late to sell Context Therapeutics Inc.2025 Winners & Losers & High Win Rate Trade Tips - newser.com

Oct 06, 2025

Oct 06, 2025

Context Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(4) - MarketScreener

Oct 06, 2025

Oct 06, 2025

Developing predictive dashboards with Context Therapeutics Inc. dataJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com

Oct 06, 2025

Oct 04, 2025

Context Therapeutics Inc. (NASDAQ:CNTX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 04, 2025

Oct 03, 2025

Context Therapeutics announces inducement grant under Nasdaq listing rule - MarketScreener

Oct 03, 2025

Oct 03, 2025

GlobeNewswire by Notified - The Manila Times

Oct 03, 2025

Oct 03, 2025

Spyre Therapeutics Announces Grants of Inducement Awards - The Manila Times

Oct 03, 2025

Oct 03, 2025

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 03, 2025

Oct 03, 2025

Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 03, 2025

Oct 03, 2025

30,000-Share Option: Context Therapeutics Grants New Hire Award at $0.97 Exercise Price, 10-year Term - Stock Titan

Oct 03, 2025

Oct 03, 2025

Context Therapeutics Gains 11%, Insider Trades Reap Benefit - simplywall.st

Oct 03, 2025